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Nonprescribed use of tranquilizers and use of other drugs
among Brazilian students
Eme´rita S. Opaleye, Cleusa P. Ferri, Danilo P. Locatelli, Tatiana C. Amato, Ana R. Noto
Department of Psychobiology, Universidade Federal de Sa˜o Paulo (UNIFESP), Sa˜o Paulo, SP, Brazil.
Objectives: To describe patterns of nonprescribed use of tranquilizers by students aged 10 to 18
years and assess the sociodemographic characteristics of these adolescents and their use of other
substances.
Methods: A randomized and stratified sample of 47,979 students from state and private schools of
the 27 Brazilian state capitals completed a self-report questionnaire. Poisson regression was used to
estimate the associations between tranquilizer use and sociodemographic factors, as well as the use
of other psychotropic substances.
Results: The lifetime prevalence of nonprescribed use of tranquilizers was 3.9%. Use was most
common among girls, wealthier adolescents, and those from private schools. An association was
found between use of tranquilizers and lifetime use of alcohol (prevalence ratio [PR] = 3.15; 95%
confidence intervals [95%CI] 2.58-3.85), tobacco (PR = 2.61; 95%CI 2.31-2.95), illicit drugs (PR =
3.70; 95%CI 3.19-4.29), and other prescription drugs (PR = 7.03; 95%CI 6.18-7.99). As the number of
substances adolescents reported having used increased, so did the nonprescribed use of
tranquilizers.
Conclusions: Nonprescribed use of tranquilizers by adolescents might indicate the use of other
substances, including high-risk combinations such as tranquilizers and alcohol. The risks of this
association should be addressed during the early stages of drug prevention programs.
Keywords: Adolescents; antianxiety agents; epidemiology; gender differences; psychoactive
substance use disorder
Introduction
Nonprescribed use of prescription drugs – use without a
physician’s prescription, even when the intended use is
self-medication – has been increasing among youths
worldwide, promoted both by ease of access and by the
false perception that medicines are completely safe.1-4
The prevalence of this behavior varies among countries
and age groups, and between genders. A recent
systematic review reported the lifetime prevalence of
such use by drug class among adolescents in the U.S.
The most commonly used medicines were opioids (13-
18%), followed by stimulants, including amphetamines
(approximately 5%), and sedatives (approximately 4%).
Most studies on the use of tranquilizers or anxiolytics
have failed to examine lifetime use rates; however, past-
year use rates range from 2 to 4.9% among individuals.5
The use of tranquilizers in Brazil gained attention
during the late 1980s due to the suggestion that part of
the population was abusing anxiolytics.6 Most such drugs
are of the benzodiazepine class, and analyses of medical
prescription records in pharmacies have shown that these
drugs are the psychotropic agents most often prescribed
by medical professionals in Brazil.7 Recent research has
indicated that tranquilizers are used over much longer
periods than recommended and might cause depen-
dence.8
Previous studies of Brazilian school populations indi-
cate that tranquilizers are the psychotropic agents most
commonly implicated in nonprescribed use among
adolescents, unlike in the U.S., where opioids are much
more common. A nationwide survey of Brazilian state
schools found that 4.1% of participants had ever used
nonprescribed tranquilizers, whereas only 0.3% had used
opioids.9 A study using a similar methodology found an
even higher prevalence (7.7%) in private and state
schools in the municipality of Passo Fundo, state of Rio
Grande do Sul.10
Despite growing use of these drugs without a prescrip-
tion, there is a shortage of information from developing
countries. In a large pharmaceutical market such as
Brazil, knowledge of the access of vulnerable populations
– including adolescents – to these substances is
important, given the failures associated with controlling
psychotropic medications and the high rate of self-
medication.11,12
Within this context, this study sought to: 1) estimate the
prevalence of nonprescribed use of tranquilizers among
10-to-18-year-old students attending the primary and
secondary schools of the state and private educational
systems in all 27 state capitals of Brazil; 2) identify the
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most vulnerable adolescents by estimating the associa-
tions between sociodemographic characteristics and
nonprescribed use of these substances; and 3) assess
whether nonprescribed use of tranquilizers by this
population is associated with use of other psychotropic
substances.
Methods
Sample
This cross-sectional study was conducted across all 27
Brazilian state capitals by the Brazilian Center for
Information on Psychotropic Drugs (CEBRID), with
funding from the National Secretariat for Drugs Policies
(SENAD), between March and October 2010. A self-
report questionnaire was administered to state and
private-school students in classrooms. The sample was
recruited from a national registry of all Brazilian state and
private schools (Instituto Nacional de Estudos e
Pesquisas Educacionais Anı´sio Teixeira, INEP).
Subsamples were drawn for each city, which generated
54 subsamples: 27 from state schools and 27 from
private schools. Given the small number of private
schools in Boa Vista, state of Roraima, and the refusal
of a great number of private schools in the city of Rio de
Janeiro to participate in the survey, data from both
capitals were pooled into a single subsample for each
city. Three strata were considered for each subsample:
schools providing primary education only, schools provid-
ing both primary and secondary education, and schools
providing secondary education only. A proportional
sample was based on the number of students (estimated
using the number of classrooms in each school) within
each stratum and a randomized process used to select
an average of three clusters (classrooms) in each school.
Finally, all students in the selected classrooms were then
invited to participate in the survey.
A total of 923 schools participated in this study: 545
state schools and 378 private schools. The average
acceptance rate was 86% (94% among state schools and
73% among private schools). The student participation
rate, which represents the number of students who
participated in the survey divided by the number of
students who officially enrolled in the classrooms drawn,
was 83% (79% in state and 92% in private schools). Only
0.3% of students who were invited to participate in the
survey refused to take part (0.2% from private and 0.4%
from state schools). This process generated a sample of
51,154 questionnaires. A dummy question concerning
drug use was included, and all questionnaires with
positive responses to that question were removed
(n=263). As all analyses were restricted to students
between the ages of 10 and 18, the final sample
consisted of 47,979 students: 17,370 from secondary
schools and 30,609 from primary schools.
Procedure
An investigator with experience in survey research
supervised each Brazilian state capital. This group of
investigators completed a 3-day training session at
Universidade Federal de Sa˜o Paulo (UNIFESP), admi-
nistered by CEBRID, and subsequently replicated this
training for the team of field researchers (i.e., inter-
viewers) in their states.
The questionnaires were administered in classroom to
students who agreed to participate in the study. On
average, the questionnaires were completed in 40
minutes, in the presence of a previously trained inter-
viewer and in the absence of school officials. The
procedures were standardized and performed on the
same day for all classes selected from the same school to
avoid confounders.
Written informed consent was obtained from the
principal of each school clarifying that the adolescents’
participation in the study was voluntary, and they would
be free to discontinue their participation at any time. They
were also notified that the information collected was
anonymous, confidential, and intended for academic
purposes only. The UNIFESP Research Ethics
Committee approved this study with protocol no. 0348/08.
Instrument
The study questionnaire was based on a specific
research instrument developed by the World Health
Organization to examine student substance use.13 This
measure has been used in prior CEBRID surveys.9
Additional questions were included on the basis of the
European School Survey Project on Alcohol and Other
Drugs (ESPAD).14
The questionnaire comprised the following sections:
Sociodemographic variables
Data concerning gender, age (open question), type of
school (state or private), and country region were
collected. The Brazilian Association of Research
Companies (ABEP) scale of socioeconomic status was
applied.15 This assessment collects data including the
level of education of the head of the household, owner-
ship of household goods (including a TV, DVD player,
cars, refrigerators, and so on), and the number of
domestic workers in the household (maid, driver, gar-
dener, and so on). The ABEP scale classifies participants
into the following social statuses, in descending order:
A1, A2, B1, B2, C1, C2, D, and E. Participants were
subsequently categorized as lower (C, D, and E), middle
(B), or upper (A) socioeconomic class for the purposes of
the present analysis.
Nonprescribed use of tranquilizers
Questions concerning the nonprescribed use of tranqui-
lizers were included. Questions regarding lifetime use,
past-year use, and past-month use were answered with
‘‘yes’’ or ‘‘no’’. The medicines mentioned as examples
were diazepam (and its trade names DienpaxH and
ValiumH), LoraxH (lorazepam), RohypnolH (flunitrazepam),
PsicosedinH (chlordiazepoxide), RivotrilH (clonazepam),
alprazolam (and its trade names AprazH and FrontalH),
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DalmadormH (flurazepam), DormonidH (midazolam), bro-
mazepam (and its trade names LexotanH and
SomaliumH), and OlcadilH (cloxazolam). The question-
naire noted that intake of teas and naturally occurring
substances, including valerian, should not be considered
part of this category. A question regarding frequency of
use was designed for past-month users, with possible
answers ranging from 1 to 5 days (sporadic use), 6 to 19
days (frequent use), and 20 days or more (heavy use).
Age at first use was also examined in the form of an open-
ended question, as was the name of the last used
medicine. This variable considered generic and trade
names, which were converted to the generic nomencla-
ture after grouping.
Use of other substances
Several questions assessed the use of other psychoac-
tive substances. In the present analysis, we collected
data on lifetime use of alcohol, tobacco, illicit drugs
(cannabis, cocaine/crack, or ecstasy), and nonprescribed
use of other prescription drugs (benzydamine, anabolic
steroids, amphetamines, or opiates). A variable, number
of drugs, was constructed by adding the lifetime use of
different drugs, except for alcohol and tobacco, by the
respondent.
Data analyses
All analyses were performed using STATA version 11.
The significance level was set at 5%. Prevalence was
expressed with regard to the sample weight using
confidence intervals. Student’s t-test was used to
examine the mean differences in participant age at the
first use of tranquilizers by gender.
A Poisson regression model was constructed to
estimate the unadjusted associations between tranquili-
zer use and age, gender, level of education, type of
school (state vs. private), socioeconomic status, and
country region. These associations were subsequently
estimated using a fitted model. Level of education was
excluded from this model because it was collinear with
age, and socioeconomic status was excluded because it
was collinear with type of school. Other Poisson regres-
sion models were constructed to estimate the associa-
tions between tranquilizer use and lifetime use of alcohol,
tobacco, illicit drugs (cannabis, cocaine/crack, or
ecstasy), other prescription drugs (benzydamine, ana-
bolic steroids, amphetamines, or opiates), and the
number of substances previously used. These models
were fit using gender, age, and type of school. The results
were expressed as prevalence ratios with 95% con-
fidence intervals and p-values.
Results
Sample characteristics
Table 1 describes the sample profile (n=47,979). Overall,
62.1% of participants were from primary schools, and
78.2% were from state schools. The largest age group
was 13-to-15-year-olds (45.2%), and females made up
the majority of the sample (52.2%).
The distribution of the weighted proportion of students
per region was based on representations per capital.
Thus, although the absolute number of participants from
the Southeast region of Brazil was not the largest, this
region comprised the largest proportion of students
(42.8%). The vast majority of students were from low-
income and middle-class socioeconomic backgrounds
(64.3%). Many respondents were grouped into a single
‘‘not reported’’ category (26.5%) because they failed to
provide all the data required to assess their socio-
economic status.
Lifetime use of tranquilizers and associated
sociodemographic factors
Of the total students interviewed, 2,124 (3.9%) reported a
lifetime nonprescribed use of tranquilizers (95%CI 3.7-
4.2). Students from the oldest age group were most likely
to report this use (Table 1): the probability of a student
reporting lifetime nonprescribed use of tranquilizers
increased by 15% with each year of life. This use was
also higher among secondary school students (PR =
1.55; 95%CI 1.35-1.78) as compared with primary school
students. However, age and level of education were
collinear in the fitted model. Girls showed a higher
prevalence of tranquilizer use, and were two times more
likely to use than boys (95%CI 1.76-2.26). An association
was found between lifetime nonprescribed use of
tranquilizers and highest socioeconomic status. This
association was noted in the bivariate analysis with
regard to both a higher prevalence of users among
students from private schools as compared with those
from state schools (PR = 1.92; 95%CI 1.69-2.18) and an
increasing prevalence ratio found among the middle and
upper socioeconomic statuses as compared with the
lower status (PR = 1.63; 95%CI 1.40-1.89 and PR = 2.52;
95%CI 2.12-3.00, respectively). Private-school students
were more than twice as likely to report using tranquili-
zers as public school students in the fitted model. Lastly,
living in the South and Center-West regions was
associated with use as compared with the Northeast
region after adjusting for age, gender, and type of school
(PR = 1.50; 95%CI 1.28-1.77 and PR = 1.18; 95%CI 1.01-
1.37, respectively).
Figure 1 shows the prevalence of lifetime nonpre-
scribed tranquilizer use by age group and gender. As
shown above, the proportion of users increases by age,
although this increase was most significant among female
adolescents.
Figure 2 shows the lifetime prevalence of nonpre-
scribed tranquilizer use per Brazilian state capital by type
of school (state or private). The highest prevalence was
recorded at private schools in Belo Horizonte, state of
Minas Gerais (9%), and the lowest rate was recorded at
state schools in Bele´m, state of Para´ (2%). The
prevalence of use in private schools was higher than in
state schools for most Brazilian state capitals, except
Goiaˆnia (state of Goia´s) and Macapa´ (state of Amapa´).
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The overall lifetime prevalence of nonprescribed use of
tranquilizers was 3.3% (95%CI 3.0-3.6) in state schools
and 6.3% (95%CI 5.7-6.9) in private schools.
Patterns of tranquilizer use
Of the 2,124 adolescents who reported lifetime use of
tranquilizers, 1,403 (65.7%) reported past-year use
(95%CI 63.0-68.0). However, only 658 adolescents
(32.7%) indicated past-month use (95%CI 29.8-35.7),
and the frequency of this use suggested that most of
these adolescents were not heavy users. Of the 658
students who reported past-month use, 534 (81.0%)
reported sporadic use (95%CI 76.0-85.0), whereas 51
adolescents (9.0%) reported frequent use (95%CI 6.4-
12.0), and 73 participants (10.1%) were heavy users
(95%CI 7.3-13.7). The mean age at first use was 13.2
years (standard error [SE] = 0.06). Although boys were
less likely to use tranquilizers than girls, their first use
tended to be at a younger age (12.8 vs. 13.5 years; p ,
0.001). The tranquilizer most frequently used by adoles-
cents was diazepam, which accounted for approximately
60% of the reports. The other medicines cited and their
respective proportions are shown in Figure 3.
Association between lifetime use of tranquilizers and use
of other substances
Lifetime tranquilizer use was associated with lifetime use
of other substances, both legal and illicit (Table 2). The
Figure 1 Lifetime nonprescribed use of tranquilizers by age
range, according to gender (n=47,979)
Table 1 Sociodemographic characteristics of the total sample and according to lifetime use of nonprescribed tranquilizers and
the prevalence rate by Poisson regression
n
Total
(n=47,979)
wgt% (95%CI) n
Lifetime use of
tranquilizers
(n=2,124)
wgt% (95%CI) PR1 (95%CI) p-value PR2 (95%CI) p-value
Age (years)*
10-12 13,785 27.5 (25.8-29.2) 324 2.2 (1.8-2.6) 1.15 (1.12-1.19) , 0.001 1.17 (1.14-1.21) , 0.001
13-15 21,807 45.2 (43.7-46.7) 1,037 4.1 (3.7-4.5)
16-18 12,387 27.4 (25.6-29.1) 763 5.3 (4.8-5.9)
Missing 150
Gender
Male 22,813 47.8 (47.2-48.5) 686 2.6 (2.3-2.9) 1.00 1.00
Female 25,001 52.2 (51.5-52.8) 1,432 5.1 (4.7-5.5) 1.97 (1.74-2.23) , 0.001 2.00 (1.77-2.27) , 0.001
Missing 165 22
Level of education
Primary 30,609 62.1 (59.8-64.3) 1,087 3.2 (2.9-3.6) 1.00 -
Secondary 17,370 37.9 (35.7-40.2) 1,037 5.0 (4.6-5.5) 1.55 (1.35-1.78) , 0.001
Type of school
State 28,759 78.2 (76.6-79.7) 990 3.3 (3.0-3.5) 1.00
Private 19,220 21.8 (20.3-23.4) 1,134 6.2 (5.7-6.9) 1.92 (1.69-2.18) , 0.001 2.09 (1.85-2.37) , 0.001
Socioeconomic
status
Lower (C-E) 13,750 33.2 (32.2-34.2) 456 3.0 (2.7-3.4) 1.00 -
Middle (B) 15,708 31.1 (30.0-32.2) 822 4.9 (4.5-5.4) 1.63 (1.40-1.89) , 0.001
Upper (A) 6,796 9.2 (8.2-10.3) 514 7.6 (6.7-8.7) 2.52 (2.12-3.00) , 0.001
Not informed 11,725 26.5 (25.6-27.4) 332 2.5 (2.1-2.9) 0.83 (0.68-1.00) 0.056
Country region
Northeast 16,503 26.2 (24.8-27.6) 725 4.0 (3.7-4.4) 1.00 1.00
North 10,619 11.8 (10.8-12.9) 444 3.7 (3.2-4.2) 0.90 (0.77-1.06) 0.224 1.03 (0.88-1.21) 0.684
Midwest 7,486 11.7 (10.7-12.7) 353 4.5 (4.0-5.2) 1.12 (0.96-1.32) 0.156 1.18 (1.01-1.37) 0.028
South 5,055 7.6 (6.8-8.3) 274 5.5 (4.8-6.2) 1.35 (1.15-1.58) , 0.001 1.50 (1.28-1.75) , 0.001
Southeast 8,316 42.8 (40.9-44.7) 328 3.4 (3.0-4.0) 0.85 (0.71-1.00) 0.064 0.94 (0.80-1.11) 0.473
95%CI = 95% confidence interval; PR1 = prevalence ratio on bivariate analysis; PR2 = prevalence ratio adjusted by age, gender, and type of
school (level of education was excluded from this model because it was collinear with age, and socioeconomic status was excluded because
it was collinear with type of school); wgt% = weighted proportions.
* Age was used as a continuous variable in the regression model.
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lifetime prevalence of alcohol use was three times higher
among adolescents who reported having used tranquili-
zers compared with non-users, and the lifetime preva-
lence of tobacco use was 2.6 times higher, even after
accounting for the major sociodemographic variables
associated with tranquilizer use (i.e., age, gender, and
type of school). Tranquilizer use was four times greater
(PR = 3.70; 95%CI 3.19-4.29) among adolescents who
reported using at least one illicit drug (cannabis, cocaine/
crack, or ecstasy). Similarly, students who reported
nonprescribed use of other prescription drugs were most
likely to use tranquilizers with regard to the variables
examined (PR = 7.03; 95%CI 6.18-7.99). The number of
substances used by adolescents was also associated
with tranquilizer use: as the number of substances
reportedly used increased, so did the prevalence of
nonprescribed tranquilizer use.
Discussion
Overall, lifetime nonprescribed use of tranquilizers was
reported by 3.9% of adolescents in this sample (3.3% of
students from state schools and 6.3% of those from
private schools). This estimated prevalence is very similar
to that found in a survey conducted 6 years earlier in state
schools only9 (3.8% among students aged 10 to 18
years).
However, the prevalence in private schools (6.3%) was
found to be twice as high as that found in state schools.
This estimate was similar to the overall prevalence found
in 31 European countries (5.6%), ranging from 1.5% in
the Ukraine to 13.6% in Lithuania.16 Likewise, the last
edition of Monitoring the Future, a survey conducted in
U.S. schools, reported a 6.3% prevalence, similar to that
found among Brazilian private-school students.17
The findings of this study also suggest that the lifetime
prevalence of nonprescribed tranquilizer use among
students from private schools in Brazil is similar to the
prevalence found among Brazilian adults. Nonprescribed
use of tranquilizers was examined in a representative
nationwide sample of the 107 largest Brazilian cities via
household surveys of 12-to-65-year-olds in 2005. Nearly
one in six respondents (5.6%) reported nonprescribed
use of tranquilizers at some time during their lives.18
However, such comparisons should be interpreted with
caution, as the methods employed to ascertain nonpre-
scribed use differed between the two surveys.
Figure 2 Lifetime nonprescribed use of tranquilizers by state capital according to type of school (n=47,979). * RJ and RR had
data from private and state schools analyzed together.
Figure 3 Benzodiazepines most commonly used by
adolescents without a medical prescription as self-reported
(n=2,124)
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This use was higher among older respondents, which
corroborates other studies of school-age adolescents.19-21
However, the cumulative effect of the question concerning
lifetime use might explain this finding.
The scientific literature has established that women are
more likely to use psychotropic medications recreationally
as compared with men, most likely because they visit
medical services more often and have a higher pre-
valence of anxiety symptoms.22,23 In the present study,
the prevalence of use among adolescent girls was almost
twice that observed in boys across all age groups.
Another factor associated with higher use among girls is
their more frequent sharing of prescriptions and medica-
tions.24
In contrast to the international literature, in which low
income is generally a risk factor for drug use,25,26
Brazilian studies have found a higher use of certain
drugs – especially alcohol – among socioeconomic
statuses with greater purchasing power.27,28 A survey of
psychotropic medication use conducted in Passo Fundo,
state of Rio Grande do Sul, found that the prevalence of
tranquilizer use was 1.3 times higher among private
schools.10 A possible hypothesis to explain this finding is
that parents’ higher purchasing power increases access
to healthcare services and, consequently, increases
adolescents’ access to medications, which are often
within reach in their own homes. A culture of tranquilizer
use might also exist among adolescents who interact in
the same social circles (e.g., private schools). The
greater use observed in private schools as compared
with state schools was evident in approximately all
Brazilian state capitals, despite the discrepancy between
the overall prevalence of use among state capitals. The
regression model indicated a higher rate of tranquilizer
use in the South and Center-West regions compared with
the Northeast region. Possible sample differences in
purchasing power might explain this finding; however,
additional research is required to better understand this
phenomenon.
The present study also found an association between
nonprescribed use of tranquilizers and use of other
substances, both legal and illicit. American adolescents
who reported using sedatives or tranquilizers recreation-
ally were approximately eight times more likely to report
a past-year use of illicit drugs than non-users.19 In a
study of 18-to-24-year-olds, past-year tranquilizer use
was strongly associated with patterns of alcohol
abuse.29 Another study indicated that lifetime nonpre-
scribed use of prescription medications was associated
with a greater likelihood of using illicit drugs and binge
drinking (five or more drinks on a single occasion) over
the past year among university students. These findings
were more significant when analyzing the use of
tranquilizers for recreational purposes (illicit drugs odds
ratio [OR] = 15.7, p , 0.001; binge drinking OR = 12.2,
p , 0.01).30
Table 2 Lifetime use of other substances, overall and according to lifetime nonprescribed use of tranquilizers, and prevalence
ratios by Poisson regression
n
Total (n=47,979)
wgt% (95%CI) n
Lifetime use of
tranquilizers
(n=2,124)
wgt% (95%CI) PR (95%CI) p-value
Alcohol
No 19,557 40.4 (39.1-41.7) 332 1.5 (1.2-1.7) 1.00
Yes 28,308 59.6 (58.3-60.9) 1,788 5.6 (5.2-5.9) 3.15 (2.58-3.85) , 0.001
Missing 114 4
Tobacco
No 40,746 84.1 (83.3-84.8) 1,412 3.0 (2.7-3.2) 1.00
Yes 7,206 15.9 (15.2-16.7) 711 8.7 (7.9-9.6) 2.61 (2.31-2.95) , 0.001
Missing 27 1
Illicit drugs*
No 45,018 94.8 (94.4-95.2) 1,733 3.3 (3.1-3.5) 1.00
Yes 2,743 5.2 (4.8-5.6) 388 13.1 (11.6-14.8) 3.70 (3.19-4.29) , 0.001
Missing 218 3
Prescription drugs
{
No 45,576 96.2 (95.9-96.5) 1,583 3.1 (2.9-3.3) 1.00
Yes 2,083 3.8 (3.5-4.1) 525 24.6 (22.1-27.2) 7.03 (6.18-7.99) , 0.001
Missing 320 3
Number of substances
{
None 43,342 91.3 (90.8-91.7) 1,378 2.8 (2.6-3.0) 1.00
One 2,910 5.9 (5.5-6.2) 431 12.2 (10.8-13.8) 4.03 (3.46-4.71) , 0.001
Two 868 1.9 (1.8-2.2) 160 16.8 (13.6-20.7) 6.10 (4.84-7.68) , 0.001
Three or more 408 0.9 (0.8-1.0) 130 31.7 (25.1-39.2) 10.92 (8.67-13.76) , 0.001
Missing 451 25
95%CI = 95% confidence interval; PR = prevalence ratio adjusted by sociodemographic factors (age, gender, and type of school); wgt% =
weighted proportions.
* Illicit drugs: cannabis, cocaine/crack, or ecstasy.
{ Prescription drugs: benzydamine, anabolic steroids, amphetamines, or opioids.
{ Only illicit drugs and nonprescribed use of prescription drugs.
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Adolescents who reported using prescription benzo-
diazepines recreationally might have more anxiety or
other mental disorder symptoms, including those asso-
ciated with social phobia. The self-medication hypothesis
of addictive disorders31 suggests that adolescent interest
in self-medication might explain their use of other
substances. Importantly, substance abuse is a multi-
factorial phenomenon that encompasses a range of
biological, psychological, and social factors. Thus, the
factors that promote an adolescent’s first use of a
substance might be the same factors that induce
nonprescribed use of prescription anxiolytics.
Although the cross-sectional nature of our study does
not allow us to establish causality, another possible
hypothesis for this behavior is based on the social
learning theory. This theory postulates that behaviors
are learned and reproduced by observing others (i.e.,
social models).32 Peralta & Steele33 concluded that social
learning theory at least partially explained the nonpre-
scribed use of psychotropics in a sample of university
students.
Nonprescribed use of prescription medicines by ado-
lescents might be affected by their observation of adults
who use these medications, including their reasons for
use (e.g., before a job interview or after an argument with
their partner). Observing adults who use tranquilizers for
reasons related to daily life might induce adolescents to
seek relief from their own discomfort via prescription
drugs. This behavior is potentially harmful to the devel-
opment of adolescents, who are still learning their limits
and potentials.
In Brazil, several factors appear to create a context
conducive to the inappropriate use of medications. One
such strong effect is the influence of the pharmaceutical
industry34 on the prescriber/user/seller triad, which
incorporates a culture of medication reinforced by the
symbolic power of medicine.35 This concept might be
assimilated as a fanciful belief that medicines are unlikely
to cause harm because they are produced with stringent
quality controls by a pharmaceutical company and used
by patients under the scrutiny of licensed physicians. This
reasoning might explain why our findings revealed a
stronger association between the use of tranquilizers and
that of other medicines with potential for abuse.
Certain limitations should be considered. Cross-
sectional surveys are designed to collect data about
outcome and exposure at the same time; therefore, the
association of factors found in this study does not imply
causality. The sample is representative of students
from Brazilian state capitals; therefore, extrapolation of
these findings to adolescents who do not attend school
or who live in cities with different characteristics should
be done with caution. Seventeen per cent of students
were absent on the day of data collection. Previous
studies have shown that absent students are more
likely to use drugs36,37; if this is true for tranquilizers,
we might have underestimated the nonprescribed use
among Brazilian students. Despite being the most cost-
effective epidemiological study method for large sam-
ples, the self-report method is subject to under- and
over-reporting.38 The use of a dummy question
regarding drug use minimized over-reporting, and
questionnaires were excluded from the analysis for
this reason. However, the strength of this survey was
that it reported unpublished nationwide data concerning
nonprescribed use of tranquilizers by adolescents. This
survey had a good response rate and voluntary
participation.
The assessment of nonprescribed use of tranquilizers
by Brazilian adolescents provides key information from a
public health standpoint. Moreover, these data help
prevent trivialization of this behavior by highlighting the
risks that result from the chronic and acute use of
anxiolytics in combination with other substances (e.g.,
alcohol). The analyses presented in this paper raised
specific concerns that should be studied to prevent this
behavior. First, although access to tranquilizers by
adolescents was not assessed in this specific analysis,
evidence suggests that nonprescribed use of tranquilizers
is associated with family influence and previous medical
prescription of tranquilizers.39 Therefore, physicians
should advise their patients about personal medical use
and the risks associated with using substances without
therapeutic monitoring so as to reduce the availability of
prescription drugs to adolescents. Pharmacists are
responsible for exerting greater control over the sale of
these medications; furthermore, guidance regarding the
storage and proper disposal of psychotropic agents
should be followed.
Another key point is the need to include specific
information about medicines in drug prevention pro-
grams. These programs should expand their discourse,
which currently focuses on drugs such as cannabis and
cocaine/crack, to substances with less visibility but great
relevance throughout life (i.e., tranquilizers). Prescription
drugs immediately follow alcohol, tobacco, and solvents
with regard to age at first use; therefore, addressing this
content in the classroom is appropriate. Prevention
programs should work with adolescents to search for
strategies that might alleviate issues related to anxiety
and insomnia without resorting to the use of medicines. In
addition, they should provide information on the potential
for dependence and the risks associated with nonpre-
scribed use of tranquilizers.
Finally, periodic epidemiological surveys are essential
to assess changes in user profiles over time and promote
immediate health measures to reach this population.
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